HONG KONG – The complexity of interactions between the interleukin-17 (IL-17) family of receptors and ligands has been elucidated in a Chinese study, which may lead to development of specific targeting strategies for treating IL-17-related autoimmune inflammatory diseases, notably psoriasis.